Synthetic Biologics (SYN) Tops Q1 EPS by 5c

Synthetic Biologics (NYSE: SYN) reported Q1 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c